SLC7A11 and central nervous system cancer: SLC7A11 overexpressing U251 glioma cells exhibit actin cytoskeletal changes reminiscent of epithelial-like cells and display an increased CSC-like phenotype, which might cause tumor drug resistance and recurrence (59).